Lanxess AG disclosed its second‑quarter 2026 results, reporting adjusted EBITDA of €152 million, marginally above the Visible Alpha consensus of €151 million, and free cash flow of €56 million, both comfortably exceeding analyst expectations. Revenue increased 6.5% year‑on‑year to €1.56 billion, driven by higher selling prices and stronger volumes. The company recorded a net loss of €53 million for the quarter, compared with a €45 million loss in the same period a year earlier.
Division‑level performance showed Specialty Additives delivering the strongest results, with EBITDA before exceptional items rising 33% to €77 million, while Consumer Protection also beat expectations. In contrast, the Advanced Intermediates segment posted EBITDA of €35 million, roughly 24% below consensus, highlighting continued weakness in parts of the chemicals market.
Looking ahead, Lanxess guided third‑quarter EBITDA before exceptional items to a range of €130 million‑€150 million, a level below analysts’ midpoint forecasts, and reaffirmed its full‑year EBITDA guidance of €450 million‑€550 million before exceptional items, without assuming any operational improvement in the second half of the year. Management emphasized ongoing restructuring measures aimed at improving long‑term profitability and described market conditions as challenging.
The market reaction was a decline of more than 3% in the share price, with the stock trading 3.2% lower at €16.63, underperforming the broader German market. Jefferies noted that the softer Q3 outlook and the miss in the Advanced Intermediates division were likely to generate slight share‑price pressure.